QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:ADMA

ADMA Biologics Earnings Date, Estimates, & History

$1.36
+0.08 (+6.25%)
(As of 12/7/2021 04:00 PM ET)
Add
Compare
Today's Range
$1.30
$1.40
50-Day Range
$1.09
$1.66
52-Week Range
$1.01
$3.11
Volume
2.22 million shs
Average Volume
4.20 million shs
Market Capitalization
$266.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.24

Earnings Summary

Upcoming
Earnings Date
Mar. 24
Estimated

Actual EPS
(Nov. 10)
-$0.13
Beat By $0.01

Consensus EPS
(Nov. 10)
-$0.14

Last Year's Q4 EPS
(11/10/2020)
-$0.19

Skip Charts & View Estimated and Actual Earnings Data

ADMA Biologics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADMA Biologics Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ADMA Biologics (NASDAQ:ADMA) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211($0.18)($0.18)($0.18) 
Q2 20211($0.16)($0.16)($0.16) 
20212($0.34)($0.34)($0.34)
Q1 20221($0.07)($0.07)($0.07) 
Q2 20221($0.07)($0.07)($0.07) 
Q3 20221($0.08)($0.08)($0.08) 
Q4 20221($0.07)($0.07)($0.07) 
FY 20224($0.29)($0.29)($0.29)

ADMA Earnings Information

ADMA Biologics last issued its quarterly earnings data on November 10th, 2021. The biotechnology company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.01. The business earned $20.68 million during the quarter, compared to analyst estimates of $18.58 million. ADMA Biologics has generated ($0.64) earnings per share over the last year (($0.64) diluted earnings per share). Earnings for ADMA Biologics are expected to grow in the coming year, from ($0.53) to ($0.28) per share. ADMA Biologics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 24th, 2022 based off prior year's report dates.

ADMA Biologics (NASDAQ:ADMA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
3/24/2022
(Estimated)
        
11/10/20219/30/2021($0.14)($0.13)+$0.01($0.13)$18.58 million$20.68 million    
8/10/20216/30/2021($0.15)($0.14)+$0.01($0.15)$16.55 million$17.83 million    
5/11/20213/31/2021($0.17)($0.16)+$0.01($0.16)$15.63 million$16.05 million  
3/24/202112/31/2020($0.17)($0.20)($0.03)($0.20)$13.90 million$13.96 million  
11/10/20209/30/2020($0.19)($0.19)($0.19)$9.55 million$10.28 million  
8/5/2020Q2 2020($0.1570)($0.23)($0.0730)($0.23)$10.29 million$7.79 million  
5/6/2020Q1 2020($0.13)($0.26)($0.13)($0.26)$10.71 million$10.20 million
3/12/202012/31/2019($0.17)($0.18)($0.01)($0.18)$11.92 million$12.04 million  
11/6/2019Q3($0.23)($0.19)+$0.04($0.19)$5.71 million$7.22 million
8/8/2019Q2 2019($0.2870)($0.25)+$0.0370($0.25)$4.36 million$6.56 million
5/8/2019Q1 2019($0.32)($0.31)+$0.01($0.34)$2.96 million$3.53 million
3/13/2019Q4 2018($0.33)($0.39)($0.06)($0.39)$5.19 million$4.06 million
11/8/2018Q3($0.31)($0.33)($0.02)($0.33)$5.39 million$4.23 million
8/10/2018Q2 2018($0.32)($0.35)($0.03)($0.35)$5.35 million$4.66 million
5/14/2018Q1 2018($0.27)($0.35)($0.08)($0.31)$7.47 million$4.04 million
3/5/2018Q4 2017($0.51)($0.24)+$0.27($0.24)$6.68 million$12.00 million
11/3/2017Q3 2017($0.51)$0.59+$1.10$0.59$6.86 million$4.73 million
8/11/2017Q2 2017($0.26)($0.55)($0.29)($0.55)$3.52 million$3.40 million
5/12/2017Q1 2017($0.2830)($0.51)($0.2270)($0.51)$3.35 million$2.63 million
2/24/2017Q4 2016($0.33)($0.35)($0.02)($0.35)$2.80 million$3.33 million
11/10/2016Q3 2016($0.42)($0.34)+$0.08($0.34)$2.32 million$2.94 million
8/12/2016Q2($0.39)($0.50)($0.11)($0.50)$2.35 million$2.27 million
5/13/2016Q1($0.37)($0.43)($0.06)($0.43)$2.48 million$2.12 million
3/23/2016Q4 2015($0.47)($0.44)+$0.03($0.44)$2.03 million$2.51 million
11/10/2015Q315($0.39)($0.48)($0.09)($0.48)$1.50 million$1.85 million
8/11/2015Q215($0.32)($0.37)($0.05)($0.30)$1.50 million$1.30 million
5/12/2015Q115($0.32)($0.37)($0.05)($0.37)$1.50 million$1.50 million
3/9/2015Q4 2014($0.38)($0.38)($0.38)$1.52 million$1.41 million
11/10/2014Q3 2014($0.37)($0.36)+$0.01($0.36)$1.37 million
8/11/2014Q2 2014($0.43)($0.43)($0.43)$1.50 million
(Earnings results data provided by Zacks Investment Research)












ADMA Biologics (NASDAQ:ADMA) Earnings Frequently Asked Questions

When is ADMA Biologics's earnings date?

ADMA Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 24th, 2022 based off last year's report dates. Learn more on ADMA's earnings history

Did ADMA Biologics beat their earnings estimates last quarter?

In the previous quarter, ADMA Biologics (NASDAQ:ADMA) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.01. Learn more on ADMA's earnings details

How can I listen to ADMA Biologics's earnings conference call?

The conference call for ADMA Biologics's latest earnings report can be listened to online. Listen to Conference Call

How can I read ADMA Biologics's conference call transcript?

The conference call transcript for ADMA Biologics's latest earnings report can be read online. Read Transcript

How much revenue does ADMA Biologics generate each year?

ADMA Biologics (NASDAQ:ADMA) has a recorded annual revenue of $42.22 million.

How much profit does ADMA Biologics generate each year?

ADMA Biologics (NASDAQ:ADMA) has a recorded net income of -$75.75 million. ADMA has generated -$0.64 earnings per share over the last four quarters.

What is ADMA Biologics's EPS forecast for next year?

ADMA Biologics's earnings are expected to grow from ($0.53) per share to ($0.28) per share in the next year.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.